Replies to post #5229 on Cytogenix (fka CYGX)

[neo43]

maskers, the IND for the herpes treatment . . .

is due by the end of April, per the last 10-Q:

We have teamed-up with a group of leading herpes and STD investigators at a large academic medical center to conduct a comprehensive cell and animal study program designed to yield safety and efficacy data in preparation for an IND submission planned for April 2004 and subsequent human trials.